| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 橘红系列(元) | 36,843,372.40 | 107,902,762.39 | 109,832,030.12 |
| 抗病毒口服液(元) | 63,995,343.15 | 83,697,335.03 | 101,129,201.11 |
| 中药材(元) | 529,877,830.20 | 936,104,066.83 | 445,203,119.57 |
| 其他(元) | 187,277,276.26 | 730,957,968.17 | 440,378,478.70 |
| 营业成本(元) | |||
| 橘红系列(元) | 29,347,613.89 | 71,369,688.24 | 45,639,703.80 |
| 抗病毒口服液(元) | 64,111,565.49 | 127,132,466.74 | 77,873,490.68 |
| 中药材(元) | 349,373,872.40 | 655,798,089.63 | 309,587,287.07 |
| 其他(元) | 141,822,576.62 | 551,506,276.64 | 301,036,915.20 |
| 毛利(元) | |||
| 橘红系列(元) | 7,495,758.51 | 36,533,074.15 | 64,192,326.32 |
| 抗病毒口服液(元) | -116,222.34 | -43,435,131.71 | 23,255,710.43 |
| 中药材(元) | 180,503,957.80 | 280,305,977.20 | 135,615,832.50 |
| 其他(元) | 45,454,699.64 | 179,451,691.53 | 139,341,563.50 |
| 毛利率(%) | |||
| 橘红系列(%) | 20.34 | 33.86 | 58.45 |
| 抗病毒口服液(%) | -0.18 | -51.90 | 23.00 |
| 中药材(%) | 34.07 | 29.94 | 30.46 |
| 其他(%) | 24.27 | 24.55 | 31.64 |
| 收入构成(%) | |||
| 橘红系列(%) | 4.50 | 5.81 | 10.02 |
| 抗病毒口服液(%) | 7.82 | 4.50 | 9.22 |
| 中药材(%) | 64.78 | 50.36 | 40.60 |
| 其他(%) | 22.89 | 39.33 | 40.16 |
| 毛利构成(%) | |||
| 橘红系列(%) | 3.21 | 8.07 | 17.71 |
| 抗病毒口服液(%) | -0.05 | -9.59 | 6.42 |
| 中药材(%) | 77.36 | 61.90 | 37.42 |
| 其他(%) | 19.48 | 39.63 | 38.45 |